Anthracycline‐based chemotherapy remains standard treatment for peripheral T‐cell
lymphoma (PTCL) although its benefits have been questioned. We performed systematic …

Peripheral T-cell lymphomas (PTCLs) are a biologically diverse and uncommon group of
diseases. Compared to their B-cell counterparts, PTCLs remain largely unexplored and the …

Purpose Peripheral T-cell lymphomas (PTCLs) are rare malignancies with poor outcome
after conventional chemotherapy. The role of myeloablative therapy and autologous stem …

Recognizing the significant biological and clinical heterogeneity of mature T cell and natural
killer (NK)/T cell lymphomas, the American Society for Blood and Marrow Transplantation …

We report the results of two prospective phase II studies investigating the role of high-dose
sequential chemotherapy, followed by autologous stem cell transplantation (ASCT) in 62 …

The peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-
Hodgkin's lymphoma. There is no uniform standard therapy for PTCL, and autologous …

Peripheral T-cell lymphomas (PTCL) are a rare and heterogeneous subset of lymphomas
with a poorer prognosis compared with B-cell lymphomas. We conducted a retrospective …

Summary The World Health Organization (WHO) lymphoma classification recognises
anaplastic large cell lymphoma (ALCL), angioimmunoblastic lymphoma (AIL) and peripheral …

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) does correspond to a
heterogeneous group of nodal and extranodal mature T-cell lymphomas, with a low …

To date, no prospective randomized trials exist comparing high-dose therapy (HDT) followed
by autologous hematopoietic cell transplantation (auto-HCT) against conventional therapy …